Name |
Configured |
[CONFIG] TB - Completed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%) |
▢ |
[CONFIG] TB - Not evaluated (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%) |
▢ |
[CONFIG] TB - Proportion of GeneXpert cartridges unusable |
▢ |
[CONFIG] TB - TB: Cured - new smear-positive (%) |
▢ |
[CONFIG] TB - DR-TB drugs wastage rate (%) |
▢ |
[CONFIG] TB - Cured (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 0-14 (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) children aged 0-14 (%) |
▢ |
[CONFIG] TB - DR-TB drugs opening balance |
▢ |
[CONFIG] TB - Lost to follow-up (new smear-positive TB cases) (%) |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on CPT at outcome |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 15-24 (%) |
▢ |
[CONFIG] TB - DS-TB drugs usable stock |
▢ |
[CONFIG] TB - DS-TB drugs opening balance |
▢ |
[CONFIG] TB - DR-TB drugs discarded |
▢ |
[CONFIG] TB - DR-TB drugs received |
▢ |
[CONFIG] TB - GeneXpert Cartridges stock out days |
▢ |
[CONFIG] TB - TB cases tested for HIV or with known HIV status (%) |
▢ |
[CONFIG] TB - Lost to follow-up (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - Died (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - GeneXpert Cartridges issued |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 35-44 (%) |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (%) |
▢ |
[CONFIG] TB - TB cases tested for HIV with positive test recorded (%) |
▢ |
[CONFIG] TB - DS-TB drugs closing balance |
▢ |
[CONFIG] TB - DR-TB drugs stock discrepancy (%) |
▢ |
[CONFIG] TB - TB cohort size (all cases, all forms) |
▢ |
[CONFIG] TB - DR-TB drugs stock out days |
▢ |
[CONFIG] TB - DR-TB drugs closing balance |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 65+ (%) |
▢ |
[CONFIG] TB - Notified TB cases (previously treated, all forms) |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on ART |
▢ |
[CONFIG] TB - Health facilities with DR-TB drugs stock-out days (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 15-24 (%) |
▢ |
[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results |
▢ |
[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 0-4 (%) |
▢ |
[CONFIG] TB - DR-TB drugs stock coverage time |
▢ |
[CONFIG] TB - Notified TB cases (previously treated including relapse, all forms) (%) |
▢ |
[CONFIG] TB - GeneXpert Cartridges redistributed |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new) (%) |
▢ |
[CONFIG] TB - Died (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - Proportion of DS-TB drugs consumed |
▢ |
[CONFIG] TB - GeneXpert Cartridges received |
▢ |
[CONFIG] TB - Died (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 5-14 (%) |
▢ |
[CONFIG] TB - Ratio of TB cases male:female (new and relapse, all forms) |
▢ |
[CONFIG] TB - TB treatment success rate (all DS-TB) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, pulmonary bacteriologically confirmed) |
▢ |
[CONFIG] GEN - Population total |
▢ |
[CONFIG] TB - Completed (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 55-64 (%) |
▢ |
[CONFIG] TB - TB cases tested for HIV or with known HIV status at outcome |
▢ |
[CONFIG] TB - Not evaluated (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - DS-TB drugs received |
▢ |
[CONFIG] TB - TB treatment success rate (previously treated DS-TB) (%) |
▢ |
[CONFIG] TB - Laboratory-confirmed MDR-TB cases |
▢ |
[CONFIG] TB - TB cases tested for HIV or with known HIV status |
▢ |
[CONFIG] TB - Proportion of GeneXpert cartridges consumed |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, pulmonary clinically diagnosed) |
▢ |
[CONFIG] TB - DS-TB drugs issued |
▢ |
[CONFIG] TB - Cured (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - TB treatment failed (new smear-positive TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 0-4 (%) |
▢ |
[CONFIG] TB - GeneXpert Cartridges discarded |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 25-34 (%) |
▢ |
[CONFIG] TB - GeneXpert cartridges stock discrepancy (%) |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (history unknown) |
▢ |
[CONFIG] TB - Completed (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - DR-TB drugs usable stock |
▢ |
[CONFIG] TB - Notified TB cases (all cases, all forms) |
▢ |
[CONFIG] TB - Failed (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - TB notification rate (new and relapse, pulmonary bacteriologically confirmed) per 100 000 population |
▢ |
[CONFIG] TB - GeneXpert cartridges closing balance |
▢ |
[CONFIG] TB - TB notification rate (new and relapse, all forms) per 100 000 population |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin |
▢ |
[CONFIG] TB - Not evaluated (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - Failed (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - Proportion of DR-TB drugs unusable |
▢ |
[CONFIG] TB - Failed (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB |
▢ |
[CONFIG] TB - Lost to follow-up (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (previously treated incl. relapse, pulmonary bacteriologically confirmed) (%) |
▢ |
[CONFIG] TB - TB notification rate (new and relapse, pulmonary clinically diagnosed) per 100 000 population |
▢ |
[CONFIG] TB - DR-TB drugs stock on hand |
▢ |
[CONFIG] TB - TB treatment success rate (new and relapse DS-TB/HIV) (%) |
▢ |
[CONFIG] TB - Cured (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - GeneXpert Cartridges stock on hand |
▢ |
[CONFIG] TB - DS-TB drugs stock on hand |
▢ |
[CONFIG] TB - Laboratory-confirmed RR-TB or MDR-TB among cases with DST results (%) |
▢ |
[CONFIG] TB - Failed (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (new) |
▢ |
[CONFIG] TB - Notified TB cases (new, pulmonary smear positive) by age group and sex |
▢ |
[CONFIG] TB - Lost to follow-up (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated) |
▢ |
[CONFIG] TB - GeneXpert usable stock |
▢ |
[CONFIG] TB - DR-TB drugs issued |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on CPT |
▢ |
[CONFIG] TB - DS-TB drugs discarded |
▢ |
[CONFIG] TB - Completed (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - DS-TB drugs stock coverage time |
▢ |
[CONFIG] TB - Notified TB cases (new, pulmonary bacteriologically confirmed) (%) |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on ART at outcome |
▢ |
[CONFIG] TB - Died (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 45-54 (%) |
▢ |
[CONFIG] TB - DR-TB drugs redistributed |
▢ |
[CONFIG] TB - DS-TB drugs stock discrepancy (%) |
▢ |
[CONFIG] TB - TB treatment success rate (all DS and DR-TB) (%) |
▢ |
[CONFIG] TB - Not laboratory-confirmed RR-TB or MDR-TB cases who started treatment for MDR-TB |
▢ |
[CONFIG] TB - TB cases tested for HIV or with known HIV status - all cases (%) |
▢ |
[CONFIG] TB - Lost to follow-up (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, all forms) aged 45-54 (%) |
▢ |
[CONFIG] TB - TB cases tested for HIV with positive test recorded |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 55-64 (%) |
▢ |
[CONFIG] TB - Not evaluated (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - Died (new smear-positive TB cases) (%) |
▢ |
[CONFIG] TB - GeneXpert Cartridges opening balance |
▢ |
[CONFIG] TB - Not evaluated (new smear-positive TB cases) (%) |
▢ |
[CONFIG] TB - Proportion of DS-TB drugs unusable |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 35-44 (%) |
▢ |
[CONFIG] TB - TB treatment success rate (all DR-TB) (%) |
▢ |
[CONFIG] TB - GeneXpert cartridges stock coverage time |
▢ |
[CONFIG] TB - TB cases tested for HIV with positive test recorded at outcome |
▢ |
[CONFIG] TB - Ratio of TB cases aged 0-4:5-14 (new and relapse, all forms) |
▢ |
[CONFIG] TB - GeneXpert cartridges wastage rate (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) by age group and sex |
▢ |
[CONFIG] TB - Cured (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 65+ (%) |
▢ |
[CONFIG] TB - Lost to follow-up (all DS-TB/HIV cases) (%) |
▢ |
[CONFIG] TB - DS-TB drugs wastage rate (%) |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on CPT (%) |
▢ |
[CONFIG] TB - Proportion of DR-TB drugs consumed |
▢ |
[CONFIG] TB - Cured (new and relapse pulmonary bacteriologically confirmed DS-TB cases) (%) |
▢ |
[CONFIG] TB - TB treatment completed (new smear-positive TB cases) (%) |
▢ |
[CONFIG] TB - TB cases tested for susceptibility to rifampicin (previously treated) (%) |
▢ |
[CONFIG] TB - Health facilities with DS-TB drugs stock-out days (%) |
▢ |
[CONFIG] TB - Notified TB cases (new, extrapulmonary) (%) |
▢ |
[CONFIG] TB - Died (previously treated DS-TB cases) (%) |
▢ |
[CONFIG] TB - TB notification rate (all cases, all forms) per 100 000 population |
▢ |
[CONFIG] TB - Failed (new and relapse pulmonary bacteriologically confirmed DS-TB cases) |
▢ |
[CONFIG] TB - Not evaluated (all DR-TB cases) (%) |
▢ |
[CONFIG] TB - Completed (all DS-TB cases) (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) |
▢ |
[CONFIG] TB - TB cases recorded as HIV positive started on ART (%) |
▢ |
[CONFIG] TB - DS-TB drugs stock out days |
▢ |
[CONFIG] TB - TB treatment success rate (new and relapse DS-TB) (%) |
▢ |
[CONFIG] TB - Health facilities with GeneXpert cartridges stock-out days (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 5-14 (%) |
▢ |
[CONFIG] TB - Notified TB cases (new and relapse, all forms) aged 25-34 (%) |
▢ |
[CONFIG] TB - DS-TB drugs redistributed |
▢ |